Vita Life Sciences Limited (ASX:VLS)
2.270
-0.230 (-9.20%)
Jan 30, 2026, 3:41 PM AEST
Vita Life Sciences Market Cap
Vita Life Sciences has a market cap or net worth of 136.55 million as of January 29, 2026. Its market cap has increased by 15.60% in one year.
Market Cap
136.55M
Enterprise Value
109.31M
Revenue
85.60M
Ranking
n/a
PE Ratio
15.10
Stock Price
2.27
Market Cap Chart
Since August 23, 2007, Vita Life Sciences's market cap has increased from 2.18M to 136.55M, an increase of 6,156.05%. That is a compound annual growth rate of 25.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 136.55M | -3.10% |
| Dec 31, 2025 | 140.92M | 26.53% |
| Dec 31, 2024 | 111.37M | 16.19% |
| Dec 27, 2023 | 95.85M | 25.15% |
| Dec 21, 2022 | 76.59M | -26.95% |
| Dec 31, 2021 | 104.86M | 93.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syntara | 55.50M |
| Medical Developments International | 54.08M |
| Next Science | 42.43M |
| Vitura Health | 37.78M |
| Little Green Pharma | 36.68M |
| IDT Australia | 21.37M |
| Peak Processing | 19.03M |
| Cann Group | 15.88M |